RBC Europe’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-175
Closed -$22.5K 1085
2021
Q3
$22.5K Sell
175
-200
-53% -$28K ﹤0.01% 755
2021
Q2
$57.2K Hold
375
﹤0.01% 561
2021
Q1
$39.5K Hold
375
﹤0.01% 606
2020
Q4
$29.7K Hold
375
﹤0.01% 629
2020
Q3
$21.2K Sell
375
-450
-55% -$24.2K ﹤0.01% 637
2020
Q2
$50.8K Hold
825
﹤0.01% 439
2020
Q1
$26.6K Hold
825
﹤0.01% 501
2019
Q4
$29K Hold
825
﹤0.01% 576
2019
Q3
$21.3K Hold
825
﹤0.01% 623
2019
Q2
$24.2K Hold
825
﹤0.01% 612
2019
Q1
$28.2K Hold
825
﹤0.01% 584
2018
Q4
$26.3K Hold
825
﹤0.01% 578
2018
Q3
$39.6K Sell
825
-210
-20% -$8.6K ﹤0.01% 531
2018
Q2
$32.1K Sell
1,035
-300
-22% -$7.02K ﹤0.01% 572
2018
Q1
$19.8K Hold
1,335
﹤0.01% 676
2017
Q4
$20.7K Hold
1,335
﹤0.01% 675
2017
Q3
$16.6K Buy
+1,335
New +$14.9K ﹤0.01% 724

Other funds holding STAA

RBC Europe's STAA Position: Q4 2021 in Review

RBC Europe sold out of STAAR Surgical (STAA) in Q4 2021, closing a stake of 175 shares — an estimated $22.5K sold.

RBC Europe first reported a position in STAA in Q3 2017 and held it in 17 quarters. The position peaked at $57.2K in Q2 2021. 279 funds tracked by Wall St. Rank hold STAA as of Q4 2021.

  • RBC Europe reported no remaining STAAR Surgical position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 175 STAAR Surgical shares in Q4 2021, an estimated $22.5K.
  • RBC Europe first reported a position in STAAR Surgical in Q3 2017 and held it in 17 quarters.
  • RBC Europe's STAAR Surgical position peaked at $57.2K in Q2 2021.
  • 279 funds tracked by Wall St. Rank held STAAR Surgical as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.